Found 23 matching trials
Palbociclib in Combination With Adjuvant Endocrine Therapy for Hormone Receptor Positive, HER2 Negative Invasive Breast Cancer PHASE2 This research study is evaluating a drug called Palbociclib in combination ...
Show More Location
University of California, San Francisco
Learn More & Join Trial
Radiation Therapy, Palbociclib, and Hormone Therapy in Treating Breast Cancer Patients With Bone Metastasis PHASE2 This phase II trial studies how well radiation therapy given with standard ...
Show More Location
Grady Health System
Learn More & Join Trial
A Study To Determine If Coadministration Of Tamoxifen Alters The Extent Or Rate Of Palbociclib (PD-0332991) Absorption Or Elimination In Healthy Male Volunteers PHASE1 A single 125 mg oral dose of the investigational compound PD-0332991 will b...
Show More Location
Pfizer Investigational Site
Learn More & Join Trial
Palbociclib for HR Positive / HER2-negative Isolated Locoregional Recurrence of Breast Cancer PHASE3 POLAR is a phase III clinical trial, which will test the safety and efficac...
Show More Status
Active Not Recruiting
Location
Medizinische Universität Graz (MUG)
Learn More & Join Trial
Neoadjuvant Endocrine Therapy, Palbociclib, Avelumab in Estrogen Receptor Positive Breast Cancer PHASE2 Eligible patients with estrogen receptor positive breast cancer will underg...
Show More Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Learn More & Join Trial
PErsonalized TREatment of High-risk MAmmary Cancer - the PETREMAC Trial PHASE2 Breast cancer is an optimal "model disease" for studying personalized medic...
Show More Status
Active Not Recruiting
Location
Akershus University Hospital
Learn More & Join Trial
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors PHASE1 Study STX-478-101 (LY4064809) is a multipart, open-label, phase 1/2 study e...
Show More Location
Ellison Clinic at Saint John's
Learn More & Join Trial
Palbociclib and Endocrine Therapy for LObular Breast Cancer Preoperative Study (PELOPS) PHASE2 This research study is evaluating how well Breast Cancer responds to preope...
Show More Status
Active Not Recruiting
Location
Stamford Hospital
Learn More & Join Trial
Palbociclib in Combination With Tamoxifen as First Line Therapy for Metastatic Hormone Receptor Positive Breast Cancer PHASE2 This is a non-randomized, open-label, single-arm, multicenter, phase II stu...
Show More Location
University of Illinois Cancer Center
Learn More & Join Trial
Neoadjuvant Hormonal Therapy Plus Palbociclib in Operable, Hormone Sensitive and HER2-Negative Primary Breast Cancer PHASE3 The study is a randomized, double blind, placebo controlled, Phase 3 clinic...
Show More Learn More & Join Trial